Home › Cancer (all types) › NCT07811258

Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer

Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer: A Pilot Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* diagnosed with breast, colorectal, lung or prostate cancer in the previous 12 months
* had no prior diagnosis of cancer
* are currently undergoing chemotherapy or radiation and/or underwent surgery in the prior 3 months
* had \>2 chronic conditions for \>1 year prior to cancer diagnosis
* are prescribed \>1 non-cancer medication(s)

Exclusion Criteria:

* cannot read and communicate in English
* do not have a smartphone

About the study

This pilot study evaluates a pharmacist-led medication adherence intervention and Medisafe mobile application among patients with newly diagnosed cancer and multimorbidity. Thirty participants will be randomized to intervention or usual care to assess feasibility, acceptability, usability, and preliminary efficacy.

What is being tested

• Medisafe Medication Management Program (behavioral)
• Pharmacist-Led Medication Review (behavioral)

Sponsor: Duke University · Participants: 30 · Started: Nov 30, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07811258

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.